SNHG8 is identified as a key regulator in non-small-cell lung cancer progression sponging to miR-542-3p by targeting CCND1/CDK6 [Erratum]
Chen C, Zhang Z, Li J, Sun Y. Onco Targets Ther. 2018;11: 6081–6090.On page 6089, the acknowledgment section was not included:AcknowledgmentThis study was funded by National Natural Science Foundation of China (No 81600217), Natural Science Foundation of Jiangsu Province (BK20160346), Jian...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-11-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | https://www.dovepress.com/snhg8-erratum-is-identified-as-a-key-regulator-in-non-small-cell-lung--peer-reviewed-article-OTT |